<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Respir Cell Mol Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Respir. Cell Mol. Biol</journal-id>
<journal-id journal-id-type="publisher-id">ajrcmb</journal-id>
<journal-title-group>
<journal-title>American Journal of Respiratory Cell and Molecular Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1044-1549</issn>
<issn pub-type="epub">1535-4989</issn>
<publisher>
<publisher-name>American Thoracic Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26949916</article-id>
<article-id pub-id-type="pmc">4942201</article-id>
<article-id pub-id-type="publisher-manuscript">2016-0052PS</article-id>
<article-id pub-id-type="doi">10.1165/rcmb.2016-0052PS</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Perspectives</subject>
<subj-group>
<subject>Obesity and Lung Disease</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Obesity and Asthma: Microbiome–Metabolome Interactions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shore</surname>
<given-names>Stephanie A.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Youngji</given-names>
</name>
</contrib>
<aff>Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence and requests for reprints should be addressed to Stephanie A. Shore, Ph.D., Department of Environmental Health, Harvard T. H. Chan School of Public Health, 665 Huntington Avenue, Boston, MA 02115. E-mail: <email xlink:href="sshore@hsph.harvard.edu">sshore@hsph.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2016</year>
<!--string-date: May 2016-->
</pub-date>
<!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
<pub-date pub-type="ppub">
<month>5</month>
<year>2016</year>
<!--string-date: May 2016-->
</pub-date>
<volume>54</volume>
<issue>5</issue>
<fpage>609</fpage>
<lpage>617</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>2</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 by the American Thoracic Society</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="rcmb.2016-0052PS.pdf"></self-uri>
<abstract>
<p>Obesity is a risk factor for asthma, but obese subjects with asthma respond poorly to standard asthma drugs. Obesity also alters gut bacterial community structure. Obesity-related changes in gut bacteria contribute to weight gain and other obesity-related conditions, including insulin resistance and systemic inflammation. Here, we review the rationale for the hypothesis that obesity-related changes in gut bacteria may also play a role in obesity-related asthma. The metabolomes of the liver, serum, urine, and adipose tissue are altered in obesity. Gut bacteria produce a large number of metabolites, which can reach the blood and circulate to other organs, and gut bacteria–derived metabolites have been shown to contribute to disease processes outside the gastrointestinal tract, including cardiovascular disease. Here, we describe the potential roles for two such classes of metabolites in obesity-related asthma: short-chain fatty acids and bile acids. Greater understanding of the role of microbiota in obesity-related asthma could lead to novel microbiota-based treatments for these hard-to-treat patients.</p>
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>airway</kwd>
<kwd>immune system</kwd>
<kwd>bile acids</kwd>
<kwd>short-chain fatty acids</kwd>
</kwd-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="0"></table-count>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>